πŸ‡ΊπŸ‡Έ FDA
Patent

US 9920047

Cyclopropanamine compound and use thereof

granted A61PA61P25/00A61P25/08

Quick answer

US patent 9920047 (Cyclopropanamine compound and use thereof) held by Takeda Pharmaceutical Company Limited expires Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Takeda Pharmaceutical Company Limited
Grant date
Tue Mar 20 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 15 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
1
CPC classes
A61P, A61P25/00, A61P25/08, A61P25/14, A61P25/16